Enliven Therapeutics, Inc.
Industry: Life Sciences ・ $ELVN on Nasdaq
Insider Sale
+$14,486
-0.05%
Shares
Shares Volume: 526 Shares
Average Share Price: $27.54
INSIDER
Kintz Samuel
PRESIDENT AND CEO (Director)
reported on Oct 3 2024
traded on Oct 1 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 1,048,729 |
| PURCHASES/SALES 1Y | 0 / 14 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $248,783.17 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 3 |
| PURCHASES/SALES 1Y | 0 / 85 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $933,320.91 |
| COMPANY PREVIOUS TRADES |